Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias.
Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias.
复制标题
多虑平对室性心律失常心脏病患者的心血管作用。
DOI:
10.1038/clpt.1987.102
复制
发表时间:
1987
影响因子:
6.7
通讯作者:
Saroff,AL
中科院分区:
文献类型:
--
作者:
Giardina,EG;Cooper,TB;Suckow,R;Saroff,AL
The effect of doxepin on ventricular arrhythmias, the ECG, and left ventricular function was evaluated in 10 cardiac patients with symptoms with frequent ventricular premature depolarizations in a dose‐ranging protocol. Four patients (40%) had ≥80% ventricular premature depolarization suppression; four of eight with pairs and four of six with ventricular tachycardia had ≥90% suppression. The mean maximal doxepin dose was 115 ± 41 mg/day; mean nadir total doxepin concentration was 61 ± 48 ng/ml and mean nadir total desmethyldoxepin concentration was 51 ± 42 ng/ml. Doxepin increased the heart rate and the PR, QRS, and QTc intervals of the surface ECG (P not significant). There was no significant change in resting mean left ventricular ejection fraction with doxepin: 41% ± 15% vs. 43% ± 19% (P not significant). Complaints of sedation (eight patients) limited dose ranging and tolerance to the drug. Although doxepin suppressed ventricular premature depolarizations in four patients, marked sedation limits its usefulness for primary treatment of arrhythmias in this population.Clinical Pharmacology and Therapeutics(1987)42,20–27; doi:10.1038/clpt.1987.102